Results 281 to 290 of about 22,534,193 (360)
Postoperative Chylous Leakage in Breast Cancer Patients: A Multicentre Case Series. [PDF]
Cheung BHH, Tse KYT, Li SWY, Kwong A.
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Cancer patients' awareness of extent of disease: anxiety, depression, quality of life. [PDF]
Manalo MFC +5 more
europepmc +1 more source
Genetic Testing for All Breast Cancer Patients: The GET FACTS Randomized Clinical Trial.
Weiss A +9 more
europepmc +1 more source
Experiences of colorectal cancer patients in Australia: a qualitative study on specialised nursing and supportive care. [PDF]
Rune KT, Ardern J, Davis C.
europepmc +1 more source
Effect of home exercise on prevention and treatment of lymphedema in breast cancer patients. [PDF]
Yin H, Wu W, Zhang Q, Xie F.
europepmc +1 more source

